A telomerase component is defective in the human disease dyskeratosis congenita

Nature

Volumn 402, Issue 6761, 1999, Pages 551-555

  Mitchell, James R ^a   Wood, Emily ^a   Collins, Kathleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CANCER RISK; CELL PROLIFERATION; DYSKERATOSIS CONGENITA; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA PROCESSING;

ADULT; AGED; AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CELL CYCLE PROTEINS; CELL NUCLEOLUS; CELLS, CULTURED; CHILD; DNA-BINDING PROTEINS; DYSKERATOSIS CONGENITA; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PSEUDOURIDINE; RECOMBINANT FUSION PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL; TELOMERASE; TRANSFECTION;

EID: 0033518188     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/990141     Document Type: Article

References (27)

1. Heiss, N. S. et al, X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genet. 19, 32-38 (1998).
2. Tollervey, D. & Kiss, T. Function and synthesis of small nucleolar RNAs. Curr. Opin. Cell Biol. 9, 337-342 (1997).
3. Mitchell, J. R., Cheng, J. & Collins, K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol. Cell. Biol. 19, 567-576 (1999).
4. Yu, G., Bradley, J. D., Attardi, L. D. & Blackburn, E. H. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344, 126-132 (1990).
5. Colgin, L. M. & Reddel, R. R. Telomere maintenance mechanisms and cellular immortalization. Curr. Opin. Genet. Dev. 9, 97-103 (1999).
6. Nugent, C. I. & Lundblad, V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12, 1073-1085 (1998).
7. Lafontaine, D. L. J., Bousquet-Antonelli, C., Henry, Y., Caizergues-Ferrer, M. & Tollervey, D. The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev. 12, 527-537 (1998).
8. Watkins, N. J. et al. Cbf5p, a potential pseudouridine synthase, and Nhp2p, a putative RNA-binding protein, are present together with Gar1p in all H BOX/ACA-motifsnoRNPs and constitute a common bipartite structure. RNA 4, 1549-1568 (1998).
9. Meier, U. T. & Blobel, G. NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria. J. Cell Biol. 127, 1505-1514 (1994).
10. Feng, J. et al. The RNA component of human telomerase. Science 269, 1236-1241 (1995).
11. Luzzatto, L. & Karadimitris, A. Dyskeratosis and ribosomal rebellion. Nature Genet. 19, 6-7 (1998).
12. Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R. R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248 (1995).
13. Bakin, A. & Ofengand, J. Four newly located pseudouridylate residues in Escherichia coli 23S ribosomal RNA are all at the peptidyltransferase center: analysis by the application of a new sequencing technique. Biochemistry 32, 9754-9762 (1993).
14. Ni, J., Tien, A. & Fournier, M. Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89, 565-573 (1997).
15. Ganot, P., Bortolin, M.-L. & Kiss, T. Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 89, 799-809 (1997).
16. Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868 (1990).
17. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990).
18. Counter, C. M., Botelho, F. M., Wang, P., Harley, C. B. & Bacchetti, S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68, 3410-3414 (1994).
19. Tahara, H. et al. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 15, 1911-1920 (1997).
20. Drachtman, R. A. & Alter, B. P. Dyskeratosis congenita: clinical features and genetic heterogeneity. J. Pediat Hematol. Oncol. 14, 297-304 (1992).
21. Dokal, I. Dyskeratosis congenita: an inherited bone marrow failute syndrome. Br. J. Haematol. 92, 775-779 (1996).
22. Marsh, J. C. W. et al. "Stem cell" origin of the hematopoietic defect in dyskeratosis congenita. Blood 79, 3138-3144 (1992).
23. Dokal, I. et al. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosome rearrangements. Blood 80, 3090-3096 (1992).
24. Sirinavin, C & Trowbridge, A. A. Dyskeratosis congenita: clinical features and genetic aspects. J. Med. Genet. 12, 339-354 (1975).
25. Trowbridge, A. A., Sirinavin, C. & Linman, J. W. Dyskeratosis congenita: hematologic evaluation of a sibship and review of the literature. Am. J. Hematol. 3, 143-152 (1977).
26. Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2014 (1994).
27. Prowse, K. R. & Greider, C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822 (1995).